News
WASHINGTON (Reuters) - U.S. health regulators have said GlaxoSmithKline Plc's Advair is safe and effective to more widely treat patients with chronic obstructive pulmonary disease (COPD), the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback